Certification Rate
77.8%
9 H-1B petitions, 77.8% certified, $187,092 median salary, FY2023–2023.
Boston, MA NAICS: 541714
The verdict
Karuna Therapeutics, Inc filed 9 H-1B petitions, more than 85% of U.S. sponsors - certified at 77.8% with a $187,092 median offered wage.
Based in Boston, MA. Computed live from U.S. Department of Labor LCA disclosures.
H-1B sponsorship profile: Karuna Therapeutics, Inc. Across U.S. Department of Labor LCA disclosures, Karuna Therapeutics, Inc filed 9 Labor Condition Applications covering 9 H-1B worker positions between fiscal year 2023 and fiscal year 2023. The employer’s DOL certification rate sits at 77.8% (7 certified of 9 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.
Compensation spread. Offered wages on Karuna Therapeutics, Inc’s H-1B petitions range from $148,824 at the low end to $250,000 at the high end, with a petition-weighted average of $187,092. That range reflects the mix of occupations the company sponsors, led by Real World Evidence Data Scientist (4 petitions at $185,000 avg), followed by Sr. Director Commercial & Analytics Operations and Senior Manager, Quality Assurance CMC. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.
Geographic footprint. Karuna Therapeutics, Inc is headquartered in Boston, MA under NAICS code 541714, and places H-1B workers across 3 states, most heavily in MA, TX, NJ. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.
Where Karuna Therapeutics, Inc ranks. By H-1B petition volume, Karuna Therapeutics, Inc is #17,879 of 119,880 employers nationally and #781 of 5,193 employers headquartered in MA. Both ranks are computed live from the same underlying petition counts, not a separate estimate.
Certification Rate
77.8%
Avg. Salary
$187,092
Median Salary
$187,092
Total Workers
9
Karuna Therapeutics, Inc vs a peer vs the national average, from DOL LCA data.
Compensation range for H-1B positions at Karuna Therapeutics, Inc
Wage vs. DOL Minimum
+35.4%
national avg +17.9%
Typical DOL Wage Level
Fully Competent (Level IV)
55.6% of petitions
Full-Time Positions
100%
Primary Worksite County
BOSTON CITY, MA
44.4% of petitions
Most frequently sponsored job titles at Karuna Therapeutics, Inc
| Job Title | Petitions | Avg. Salary |
|---|---|---|
| Real World Evidence Data Scientist | 4 | $185,000 |
| Sr. Director Commercial & Analytics Operations | 1 | $250,000 |
| Senior Manager, Quality Assurance CMC | 1 | $148,824 |
| Senior Manager, Drug Product Commercial Manufacturing | 1 | $170,000 |
| Senior Manager, Analytical Development | 1 | $150,000 |
| Director, Pharmacovigilance Scientist | 1 | $225,000 |
Where Karuna Therapeutics, Inc places H-1B workers across the United States
Latest H-1B labor condition applications filed by Karuna Therapeutics, Inc
| Job Title | Location | Salary | Status | Year |
|---|---|---|---|---|
| Senior Manager, Drug Product Commercial Manufacturing | Boston, MA | $170,000 | Certified | FY2023 |
| Director, Pharmacovigilance Scientist | Boston, MA | $225,000 | Certified | FY2023 |
| Senior Manager, Analytical Development | Floor 26, MA | $150,000 | Certified | FY2023 |
| Senior Manager, Quality Assurance CMC | Boston, MA | $148,824 | Certified | FY2023 |
| Sr. Director Commercial & Analytics Operations | Secaucus, NJ | $250,000 | Certified | FY2023 |
| Real World Evidence Data Scientist | Fort Worth, TX | $185,000 | Certified | FY2023 |
| Real World Evidence Data Scientist | Fort Worth, TX | $185,000 | Withdrawn | FY2023 |
| Real World Evidence Data Scientist | Fort Worth, TX | $185,000 | Certified | FY2023 |
| Real World Evidence Data Scientist | Fort Worth, TX | $185,000 | Withdrawn | FY2023 |
Other H-1B sponsors based in MA, ranked by petition volume
Compare Karuna Therapeutics, Inc vs Fidelity Technology Group, LLC side-by-side →
Essential resources for understanding H-1B visa sponsorship
Step-by-step guide from LCA filing to work authorization
Understanding prevailing wage levels I through IV
How to read and interpret DOL LCA disclosure data
Compare salaries by occupation, state, and wage level
Karuna Therapeutics, Inc has filed 9 H-1B LCA petitions covering 9 worker positions from FY2023 to FY2023.
Karuna Therapeutics, Inc has a 77.8% certification rate, with 7 out of 9 petitions certified.
The average H-1B salary at Karuna Therapeutics, Inc is $187,092. Salaries range from $148,824 to $250,000.
The top H-1B job titles at Karuna Therapeutics, Inc include Real World Evidence Data Scientist , Sr. Director Commercial & Analytics Operations, Senior Manager, Quality Assurance CMC. The most common position is Real World Evidence Data Scientist with 4 petitions at an average salary of $185,000.
Karuna Therapeutics, Inc is headquartered in Boston, MA. Their H-1B workers are distributed across 3 states, with the most positions in MA, TX, NJ.
No, Karuna Therapeutics, Inc is not classified as H-1B dependent.
H-1B visa petition data is sourced from the U.S. Department of Labor (DOL) Labor Condition Application (LCA) disclosure files. Data covers fiscal years 2023 through 2026. Salary figures reflect amounts listed on LCA petitions, not actual compensation paid. Certification of an LCA does not guarantee visa approval.
Source: DOL Foreign Labor Performance Data
Source: U.S. Department of Labor, Office of Foreign Labor Certification, LCA Disclosure Data (FY2023–FY2026)
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the U.S. Department of Labor LCA disclosure files. Consult a qualified professional before making decisions based on this data.
Read our methodology , how this data is sourced, computed, and verified.
Every figure on PlainVisa is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.